Pharmacotherapy of Cystic Fibrosis

For the 89,000 patients with cystic fibrosis worldwide, mucolytics, anti-inflammatories, and antibiotics should be used for first-line pulmonary treatments, authors of a review article conclude,

Read More »

Around the Web — 2.21.23

FDA last week approved velmanase alfa (Lamzede), the first enzyme replacement therapy approved in the U.S. for the treatment of non-central nervous system manifestations of alpha-mannosidosis,

Read More »